Recent research suggests GLP‑1 receptor agonists, including drugs like Ozempic, Wegovy, Mounjaro, and Trulicity, may have a positive impact on testosterone levels in men and promote weight loss. A study presented at ENDO 2025 revealed that men taking these medications experienced a significant increase in testosterone levels, reaching about 77% of normal levels, coupled with an average weight loss of 10%. By targeting fat reduction, insulin resistance, inflammation, and estrogen-to-testosterone conversion, these drugs offer dual benefits for both metabolic and men’s health. Learn more about this breakthrough in hormonal health and weight management.
